Ambu A/S (AMBU-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ambu A/S (AMBU-B) has a cash flow conversion efficiency ratio of 0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr255.00 Million ≈ $39.90 Million USD) by net assets (Dkr6.10 Billion ≈ $954.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AMBU-B net asset quality score to measure how much of total assets are equity-financed.
Ambu A/S - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Ambu A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AMBU-B cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Ambu A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ambu A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IRB Infrastructure Developers Limited
NSE:IRB
|
0.052x |
|
Winner Medical Co Ltd
SHE:300888
|
0.031x |
|
K+S Aktiengesellschaft
F:SDF1
|
0.030x |
|
OneSpaWorld Holdings Ltd
NASDAQ:OSW
|
0.016x |
|
Shanghai Phichem Material Co Ltd Class A
SHE:300398
|
0.030x |
|
Ratch Group Public Company Limited
BK:RATCH
|
0.054x |
|
Eurazeo
PA:RF
|
0.012x |
|
Kaiser Aluminum Corporation
NASDAQ:KALU
|
0.100x |
Annual Cash Flow Conversion Efficiency for Ambu A/S (2002–2025)
The table below shows the annual cash flow conversion efficiency of Ambu A/S from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Ambu A/S stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Dkr6.04 Billion ≈ $944.22 Million |
Dkr791.00 Million ≈ $123.76 Million |
0.131x | -9.82% |
| 2024-09-30 | Dkr5.59 Billion ≈ $875.22 Million |
Dkr813.00 Million ≈ $127.20 Million |
0.145x | +51.31% |
| 2023-09-30 | Dkr5.39 Billion ≈ $843.77 Million |
Dkr518.00 Million ≈ $81.04 Million |
0.096x | +330.81% |
| 2022-09-30 | Dkr4.26 Billion ≈ $666.66 Million |
Dkr95.00 Million ≈ $14.86 Million |
0.022x | -73.14% |
| 2021-09-30 | Dkr3.95 Billion ≈ $618.32 Million |
Dkr328.00 Million ≈ $51.32 Million |
0.083x | -33.27% |
| 2020-09-30 | Dkr2.37 Billion ≈ $371.12 Million |
Dkr295.00 Million ≈ $46.15 Million |
0.124x | -49.09% |
| 2019-09-30 | Dkr2.18 Billion ≈ $341.39 Million |
Dkr533.00 Million ≈ $83.39 Million |
0.244x | -17.02% |
| 2018-09-30 | Dkr1.88 Billion ≈ $294.45 Million |
Dkr554.00 Million ≈ $86.68 Million |
0.294x | -18.51% |
| 2017-09-30 | Dkr1.28 Billion ≈ $200.11 Million |
Dkr462.00 Million ≈ $72.28 Million |
0.361x | -2.89% |
| 2016-09-30 | Dkr992.00 Million ≈ $155.21 Million |
Dkr369.00 Million ≈ $57.73 Million |
0.372x | +85.27% |
| 2015-09-30 | Dkr1.04 Billion ≈ $162.09 Million |
Dkr208.00 Million ≈ $32.54 Million |
0.201x | -6.31% |
| 2014-09-30 | Dkr854.00 Million ≈ $133.61 Million |
Dkr183.00 Million ≈ $28.63 Million |
0.214x | +17.15% |
| 2013-09-30 | Dkr667.00 Million ≈ $104.36 Million |
Dkr122.00 Million ≈ $19.09 Million |
0.183x | -21.31% |
| 2012-09-30 | Dkr678.11 Million ≈ $106.09 Million |
Dkr157.62 Million ≈ $24.66 Million |
0.232x | +32.05% |
| 2011-09-30 | Dkr579.86 Million ≈ $90.72 Million |
Dkr102.07 Million ≈ $15.97 Million |
0.176x | +0.20% |
| 2010-09-30 | Dkr561.60 Million ≈ $87.87 Million |
Dkr98.66 Million ≈ $15.44 Million |
0.176x | -25.45% |
| 2009-09-30 | Dkr479.62 Million ≈ $75.04 Million |
Dkr113.02 Million ≈ $17.68 Million |
0.236x | +26.10% |
| 2008-09-30 | Dkr452.01 Million ≈ $70.72 Million |
Dkr84.47 Million ≈ $13.22 Million |
0.187x | -11.51% |
| 2007-09-30 | Dkr418.18 Million ≈ $65.43 Million |
Dkr88.31 Million ≈ $13.82 Million |
0.211x | -16.11% |
| 2006-09-30 | Dkr391.07 Million ≈ $61.19 Million |
Dkr98.44 Million ≈ $15.40 Million |
0.252x | +119.03% |
| 2005-09-30 | Dkr349.14 Million ≈ $54.63 Million |
Dkr40.13 Million ≈ $6.28 Million |
0.115x | -32.82% |
| 2004-09-30 | Dkr320.14 Million ≈ $50.09 Million |
Dkr54.77 Million ≈ $8.57 Million |
0.171x | -20.36% |
| 2003-09-30 | Dkr294.12 Million ≈ $46.02 Million |
Dkr63.18 Million ≈ $9.88 Million |
0.215x | +138.91% |
| 2002-09-30 | Dkr283.94 Million ≈ $44.43 Million |
Dkr25.53 Million ≈ $3.99 Million |
0.090x | -- |
About Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more